RS Crum Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$483K Hold
417
– – 0.09% 66
2026
Q2
$500K Sell
417
-10
-2% -$10.2K 0.09% 63
2026
Q1
$393K Sell
427
-6
-1% -$6.08K 0.08% 73
2025
Q4
$465K Hold
433
– – 0.09% 62
2025
Q3
$330K Sell
433
-4
-0.9% -$2.98K 0.07% 79
2025
Q2
$341K Sell
437
-21
-5% -$16.3K 0.08% 71
2025
Q1
$378K Buy
458
+49
+12% +$40.8K 0.1% 64
2024
Q4
$316K Buy
409
+2
+0.5% +$1.66K 0.08% 74
2024
Q3
$360K Buy
407
+93
+30% +$83.6K 0.08% 71
2024
Q2
$284K Buy
+314
New +$251K 0.07% 76

Other funds holding LLY

RS Crum Inc's LLY Position: Q3 2026 in Review

RS Crum Inc held its Eli Lilly (LLY) position steady in Q3 2026 at 417 shares worth $483K. The position accounts for 0.09% of the portfolio, ranked #66.

RS Crum Inc first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $500K in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RS Crum Inc held 417 shares of Eli Lilly worth $483K as of Q3 2026.
  • RS Crum Inc left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.09% of RS Crum Inc's portfolio in Q3 2026, its #66 holding.
  • RS Crum Inc first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • RS Crum Inc's Eli Lilly position peaked at $500K in Q2 2026.
  • 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RS Crum Inc's 13F filing for Q3 2026, filed 19 Oct 2026.